Showing results (451-460 of 974) with videos related to
Sort By:
Pageof 98
Cancers|March 10, 2022
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor TherapyMitchell S von Itzstein, Amrit S Gonugunta, Thomas Sheffield, et al.Cancers|May 14, 2025
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil ModelHui Li, Morteza Salehjahromi, Myrna C B Godoy, et al.Biorxiv : the Preprint Server for Biology|June 25, 2024
Differences in systemic immune parameters in individuals with lung cancer according to raceMitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.JTO Clinical and Research Reports|December 2, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung CancerMitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.The Journal of Clinical Investigation|April 4, 2018
TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancerKe Gong, Gao Guo, David E Gerber, et al.Journal for Immunotherapy of Cancer|January 20, 2023
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumorsCharles M Rudin, Hardev S Pandha, Matthew Zibelman, et al.Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancerDavid E Gerber, Mark A Socinski, Joel W Neal, et al.Cancer Cell|October 20, 2023
Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancerAnanda M Rodilla, Rajesh M Valanparambil, Philip C Mack, et al.The Journal of Clinical Investigation|December 21, 2013
Angiotensin II-dependent TGF-β signaling contributes to Loeys-Dietz syndrome vascular pathogenesisElena M Gallo, David C Loch, Jennifer P Habashi, et al.Journal for Immunotherapy of Cancer|September 10, 2025
Innate and adaptive immune features associated with immune-related adverse eventsShaheen Khan, Venkat S Malladi, Mitchell S von Itzstein, et al.Pageof 98